| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 07/27/2006 | US20060166962 2-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methyl}1-oxypiperazinyl)methyl]phenoxy}pyrimidine; insecticide, controlling tobacco budworm, wheat, corn, soybeans, potatoes, and cotton; for soil-borne insects, such as termites and white grubs |
| 07/27/2006 | US20060166961 Cell adhesion inhibitors |
| 07/27/2006 | US20060166895 N-heterocyclic hydroxyethylamine compounds; human immunodeficiency virus (HIV) protease |
| 07/27/2006 | US20060165605 Process to regenerate fcc spent catalyst |
| 07/27/2006 | DE102005001411A1 Substituierte 4-Phenyltetrahydroisochinoline, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, sowie sie enthaltendes Medikament Substituted 4-Phenyltetrahydroisochinoline, processes for their preparation, their use as a medicament, and medicament containing them |
| 07/27/2006 | CA2601326A1 2,5-disubstituted phenyl methanone derivatives as glycine transporter 1(glyt-i) inhibitors for the treatment of neurological and neuropsychiatric disorders |
| 07/27/2006 | CA2595574A1 Chemical compounds |
| 07/27/2006 | CA2595173A1 N-substituted heterocyclic sulfonamides |
| 07/27/2006 | CA2595157A1 Imidazole and benzimidazole derivatives useful as histamine h3 antagonists |
| 07/27/2006 | CA2594940A1 Cgrp receptor antagonists |
| 07/27/2006 | CA2594878A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2594777A1 Indoles useful in the treatment of inflamation |
| 07/27/2006 | CA2594773A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2594567A1 Fluoroalkylpyrrolidine derivative |
| 07/27/2006 | CA2593656A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s |
| 07/27/2006 | CA2593560A1 4- (2, 6-dichlorobenzoylamino) -lh-pyrazole-3 -carboxylic acid piperidin- 4 -ylamid acid addition salts as kinase inhibitors |
| 07/27/2006 | CA2593468A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s |
| 07/27/2006 | CA2593465A1 Pyrazole derivatives for the inhibition of cdk' s and gsk' s |
| 07/27/2006 | CA2593166A1 Mitotic kinesin inhibitors |
| 07/27/2006 | CA2593155A1 Indoles useful in the treatment of inflammation |
| 07/27/2006 | CA2587455A1 Substituted pyrazoles, compositions thereof, and their use as pesticides |
| 07/26/2006 | EP1683804A2 Platinum complex and luminescent element |
| 07/26/2006 | EP1682540A1 Azolidinecarbonitriles and their use as dpp-iv inhibitors |
| 07/26/2006 | EP1682537A1 Modulators of cellular adhesion |
| 07/26/2006 | EP1682535A1 Heteroaryl derivatives as ppar activators |
| 07/26/2006 | EP1682529A2 Methods for synthesizing quinolinone compounds |
| 07/26/2006 | EP1682528A1 BENZO [b][1,4] DIOXEPINE DERIVATIVES |
| 07/26/2006 | EP1682520A1 Amide derivatives |
| 07/26/2006 | EP1682519A1 Pyridazin-3(2h)-one derivatives and their use as pde4 inhibitors |
| 07/26/2006 | EP1682518A1 Dicationic triaryl analogs as anti-protozoan agents |
| 07/26/2006 | EP1682517A1 Process for the synthesis of imidazoles |
| 07/26/2006 | EP1682516A2 Immobilized n-substituted tricyclic 3-aminopyrazoles for the identification of biomolecular targets |
| 07/26/2006 | EP1682510A2 Methods and compositions for selectin inhibition |
| 07/26/2006 | EP1682500A1 Process for the preparation of ccr-2 antagonist |
| 07/26/2006 | EP1682491A1 Non-symmetrical gelling agent |
| 07/26/2006 | EP1682141A1 4-fluoro-4-(pyridin-2-yl)-piperidine-1-carboxamide derivatives and related compounds which modulate the function of the vanilloid-1 receptor (vr1) for the treatment of pain |
| 07/26/2006 | EP1682139A1 Preparation of pharmaceutical salts of 1, 4 - bipiperidine |
| 07/26/2006 | EP1682138A2 Heterocyclic inhibitors of mek and methods of use thereof |
| 07/26/2006 | EP1682126A1 Substituted benzazoles and use thereof as inhibitors of raf kinase |
| 07/26/2006 | EP1682121A1 Use of crth2 antagonist compounds in therapy |
| 07/26/2006 | EP1682120A2 Fused phenylalanine derivatives as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 07/26/2006 | EP1448552B1 Quinoline derivatives, process for preparing them and use for the treatment of diseases mediated by s-cd23 |
| 07/26/2006 | EP1244451B1 Substituted piperazine and piperidine calcium channel blockers |
| 07/26/2006 | EP1192950B1 Therapeutic drugs for dermatitis exhibiting a biphasic skin reaction containing chymase inhibitors as the active ingredient |
| 07/26/2006 | CN1809556A Processes for the preparation of 1-[(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 07/26/2006 | CN1809555A Metabolites of tricyclic amides useful for inhibition of G-protein function and methods of treatment of proliferative diseases |
| 07/26/2006 | CN1809554A 3-substituted 5,6-diaryl-pyrazine-2-carboxamide and -2-sulfonamide derivatives as cb1 modulators |
| 07/26/2006 | CN1809553A Piperazine derivatives and their use for the treatment of neurological and psychiatric diseases |
| 07/26/2006 | CN1809540A Inhibitors of Akt activity |
| 07/26/2006 | CN1809539A Pyrimidine derivatives useful for the treatment of diseases mediated by CRTH2 |
| 07/26/2006 | CN1809538A Cis-2,4,5-triaryl-imidazolines |
| 07/26/2006 | CN1809536A Inhibitors of Akt activity |
| 07/26/2006 | CN1809360A 4-anilino-quinazoline derivatives as antiproliferative agents |
| 07/26/2006 | CN1809354A Akt活性抑制剂 Akt activity inhibitor |
| 07/26/2006 | CN1809349A 5-oxo and 5-thio derivatives of 5h-indeno'1,2-bipyridine with adenosine A2A receptor binding and phosphodiesterase inhibiting activity for the treatment of neurodegenerative disorders and inflammation |
| 07/26/2006 | CN1809346A Preparation of pyrrolidine-1,2-dicarboxanilide derivatives for use as factor XA and VIIA inhibiting antithrombotic agents, comprises reacting pyrrolidine-2-carboxylic acid with phenyl isocyanate then |
| 07/26/2006 | CN1807426A Heteroaryl urea neuropeptide y y5 receptor antagonists |
| 07/26/2006 | CN1807425A Method for purifying halofuginone and its special immune affinity chromatographic column |
| 07/26/2006 | CN1266148C Method for producing 2-azetidinone derivative |
| 07/26/2006 | CN1266138C Gyrase imhibitors and uses thereof |
| 07/26/2006 | CN1266112C Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 07/25/2006 | US7081534 Process for the preparation of pantoprazole and salts thereof |
| 07/25/2006 | US7081532 N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-4-piperazin-1-ylmethyl-benzamide or salt; antiproliferative agent |
| 07/25/2006 | US7081470 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods |
| 07/25/2006 | US7081468 Angiogenesis inhibitors; antitumor agents; skin disorders; antiarthritic agents |
| 07/25/2006 | US7081466 anticarcinogenic agents with improved efficacy against multidrug resistant tumors; improved oral bioavailability and side effect reduction |
| 07/25/2006 | US7081463 Hydroxy alkyl substituted 1,3,8-Triazaspiro[4.5]decan-4-one derivatives useful for the treatment of orl-1receptor mediated disorders |
| 07/25/2006 | US7081461 Quinazoline compounds and pharmaceutical compositions containing them |
| 07/25/2006 | US7081460 Quinazoline and quinazoline-like compounds for the treatment of integrin-mediated disorders |
| 07/25/2006 | US7081459 1-substituted pyridine-2-ones or 2-substituted pyridazin-3-ones; anticarcinogenic agents for breast and prostate cancer; contraceptives; endometriosis, benign prostatic hypertophy |
| 07/25/2006 | US7081458 Small molecule, non-peptide antagonists; antidiabetic agents; obesity; {5-[1-4-Methoxy-2,3-dimethyl-phenyl)-ethyl]-(1S,4S)-2,5-diaza-bicyclo[2.2.1]hept-2-yl}-(4-trifluoromethyl-phenyl)-methanone |
| 07/25/2006 | US7081454 Anticancer agents |
| 07/25/2006 | US7081279 Alkenyl compound having a negative Δε value, liquid crystal composition, and liquid crystal display device |
| 07/25/2006 | CA2259218C Tetrahydrobenzindole compound |
| 07/25/2006 | CA2159603C Quinolines as type iv phosphodiesterase inhibitors |
| 07/20/2006 | WO2006076706A1 Cinnamide and hydrocinnamide derivatives with raf-kinase inhibitory activity |
| 07/20/2006 | WO2006076702A1 MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-ĸB ACTIVITY AND USE THEREOF |
| 07/20/2006 | WO2006076644A2 Heteroaryl sulfonamides and ccr2 |
| 07/20/2006 | WO2006076593A1 1,3-diaryl substituted ureas as modulators of kinase activity |
| 07/20/2006 | WO2006076592A1 1,3 substituted diaryl ureas as modulators of kinase activity |
| 07/20/2006 | WO2006076529A1 Indole derivatives for treating viral infections |
| 07/20/2006 | WO2006076318A1 Monopotassium salt of an ikb kinase inhibitor |
| 07/20/2006 | WO2006076246A2 Phenylglycinamide derivatives useful as anticoagulants |
| 07/20/2006 | WO2006076243A1 Processes for preparing 4-(phenoxy-5-methyl-pyrimidin-4-yloxy)piperidine-1-carboxylic acid derivatives and related compounds |
| 07/20/2006 | WO2006075955A1 Pyrazolyl acylsulfonamide derivatives as endothelin converting enzyme inhibitors and useful in the treatment of chronic obstructive pulmonary disease |
| 07/20/2006 | WO2006075706A1 Anthrapyridone compound, magenta ink composition and colored matter |
| 07/20/2006 | WO2006075619A1 2-(cyclic aminocarbonyl)indoline derivative and medicinal composition containing the same |
| 07/20/2006 | WO2006075226A1 11c-labeled benzyl-lactam compounds and their use as imaging agents |
| 07/20/2006 | WO2006075152A1 4- (1h-indol-3-yl) -pyrimidin-2-ylamine derivates and their use in therapy |
| 07/20/2006 | WO2006074952A1 Process for preparing lansoprazole |
| 07/20/2006 | WO2006074924A1 3,4,(5)-substituted tetrahvdropyridines |
| 07/20/2006 | WO2006074789A1 1h-indole-3-carboxylic acid derivatives and their use as ppar agonists |
| 07/20/2006 | WO2006060762A3 Pyrazole derivatives as modulators of the 5-ht2a serotonin receptor useful for the treatment of disorders related thereto |
| 07/20/2006 | WO2006060318A3 Quinolines and quinazoline analogs and their use as medicaments for treating cancer |
| 07/20/2006 | WO2006052546A3 Pyrazolylmethyl heteroaryl derivatives |
| 07/20/2006 | WO2006015159A3 Potassium channel inhibitors |
| 07/20/2006 | WO2005123033A3 Fine particles of cilostazol and processes for production thereof |
| 07/20/2006 | WO2005121130A3 Chemical compounds and pharmaceutical compositions containing them for the treatment of inflammatory disorders |
| 07/20/2006 | US20060161004 Quinoline derivatives for therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper-reactivity, cough, inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 07/20/2006 | US20060161002 Tetrahydrocarbazole derivatives and their pharmaceutical use |